Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 4:07 pm Sale | 13G | IDEAYA BIOSCIENCES INC IDYA | PERCEPTIVE ADVISORS LLC | 1,141,484 5.6% | -200,000 (-14.91%) | View |
2020-02-14 4:06 pm Sale | 13G | NEUROCRINE BIOSCIENCES INC NBIX | PERCEPTIVE ADVISORS LLC | 3,612,554 3.9% | -996,000 (-21.61%) | View |
2020-02-14 4:04 pm Unchanged | 13G | ONCTERNAL THERAPEUTICS INC ONCT | PERCEPTIVE ADVISORS LLC | 0 0% | 0 (Unchanged) | View |
2020-02-14 4:03 pm Purchase | 13G | GLOBAL BLOOD THERAPEUTICS INC GBT | PERCEPTIVE ADVISORS LLC | 5,865,726 9.7% | 440,000 (+8.11%) | View |
2020-02-14 4:01 pm Purchase | 13G | AMICUS THERAPEUTICS INC FOLD | PERCEPTIVE ADVISORS LLC | 25,132,364 9.9% | 4,407,940 (+21.27%) | View |
2020-02-14 4:00 pm Sale | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | PERCEPTIVE ADVISORS LLC | 0 0% | -1,365,579 (Position Closed) | View |
2020-02-14 4:00 pm Purchase | 13G | KODIAK SCIENCES INC KOD | PERCEPTIVE ADVISORS LLC | 3,663,557 8.5% | 528,358 (+16.85%) | View |
2020-02-14 4:00 pm Sale | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | PERCEPTIVE ADVISORS LLC | 9,411,396 7.5% | -2,829,909 (-23.12%) | View |
2020-02-14 3:59 pm Purchase | 13G | AQUESTIVE THERAPEUTICS INC AQST | PERCEPTIVE ADVISORS LLC | 2,250,000 7% | 136,600 (+6.46%) | View |
2020-02-14 3:59 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PERCEPTIVE ADVISORS LLC | 3,297,522 7.7% | 80,000 (+2.49%) | View |
2020-02-14 3:59 pm Sale | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | PERCEPTIVE ADVISORS LLC | 0 0% | -2,253,376 (Position Closed) | View |
2020-02-14 3:58 pm Purchase | 13G | QUOTIENT LIMITED QTNT | PERCEPTIVE ADVISORS LLC | 13,289,054 16.5% | 2,500,000 (+23.17%) | View |
2020-02-14 3:58 pm Purchase | 13G | ADMA BIOLOGICS INC ADMA | PERCEPTIVE ADVISORS LLC | 16,084,802 19.4% | 4,563,700 (+39.61%) | View |
2020-02-14 3:57 pm Unchanged | 13G | ALBIREO PHARMA INC ALBO | PERCEPTIVE ADVISORS LLC | 1,704,330 13.4% | 0 (Unchanged) | View |
2020-02-14 3:57 pm Unchanged | 13G | FREQUENCY THERAPEUTICS INC FREQ | PERCEPTIVE ADVISORS LLC | 3,034,296 9.9% | 0 (Unchanged) | View |
2020-02-14 3:55 pm Unchanged | 13G | ALDEYRA THERAPEUTICS, INC ALDX | PERCEPTIVE ADVISORS LLC | 3,085,458 11% | 0 (Unchanged) | View |
2020-02-14 3:54 pm Unchanged | 13G | FOAMIX PHARMACEUTICALS LTD FOMX | PERCEPTIVE ADVISORS LLC | 11,203,881 18.3% | 0 (Unchanged) | View |
2020-02-14 3:53 pm Unchanged | 13G | AGILE THERAPEUTICS INC AGRX | PERCEPTIVE ADVISORS LLC | 11,919,925 18.5% | 0 (Unchanged) | View |
2020-02-14 3:52 pm Purchase | 13G | SOLID BIOSCIENCES INC SLDB | PERCEPTIVE ADVISORS LLC | 6,749,803 14.7% | 2,822,581 (+71.87%) | View |
2020-02-14 3:50 pm Purchase | 13G | KADMON HLDGS LLC COM KDMN | PERCEPTIVE ADVISORS LLC | 15,165,747 9.5% | 2,000,001 (+15.19%) | View |